Roundtable Discussion: Advancing Patient Selection & Monitoring Across Therapeutics Modalities in Precision Oncology for Improved Clinical Outcomes
Time: 3:55 pm
day: Day 1 - Track A (2)
Details:
- How can you optimise the use of tumour and blood-based biomarkers for dynamic patient selection?
- How to address the challenge of biomarker heterogeneity within solid tumors and its impact on accurate patient stratification
- Why is biomarker assay standardisation critical for clinical adoption, and what collaborative efforts can streamline this process?
